About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 594056, 12 pages
http://dx.doi.org/10.1155/2012/594056
Research Article

Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions

1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA
2Department of Microbiology and Molecular Biology, Brigham Young University, 857 WIDB, Provo, UT 84604, USA
3Division of Rheumatology, Cincinnati Children’s Hospital, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
4Departments of Medicine and Pathology, The University of Oklahoma Health Sciences Center, 1100 N. Lindsay, Oklahoma City, OK 73104, USA

Received 5 May 2011; Revised 4 November 2011; Accepted 5 November 2011

Academic Editor: Timothy B. Niewold

Copyright © 2012 Joel M. Guthridge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Deapen, A. Escalante, L. Weinrib et al., “A revised estimate of twin concordance in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 35, no. 3, pp. 311–318, 1992. View at Scopus
  2. S. R. Block, “A brief history of twins,” Lupus, vol. 15, no. 2, pp. 61–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Guo, H. Deshmukh, R. Lu et al., “Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population,” Genes & Immunity, vol. 10, no. 5, pp. 531–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Han, X. Kim-Howard, H. Deshmukh et al., “Evaluation of imputation-based association in and around the integrin-α-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE),” Human Molecular Genetics, vol. 18, no. 6, pp. 1171–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Liu, Q. Z. Li, A. M. Delgado-Vega et al., “Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans,” The Journal of Clinical Investigation, vol. 119, no. 4, pp. 911–923, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Lu, G. S. Vidal, J. A. Kelly et al., “Genetic associations of LYN with systemic lupus erythematosus,” Genes & Immunity, vol. 10, no. 5, pp. 397–403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Namjou, A. L. Sestak, D. L. Armstrong et al., “High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups,” Arthritis & Rheumatism, vol. 60, no. 4, pp. 1085–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. V. Kozyrev, A. K. Abelson, J. Wojcik et al., “Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 2, pp. 211–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Y. Demirci, S. Manzi, R. Ramsey-Goldman et al., “Association of a Common Interferon Regulatory Factor 5 (IRF5) variant with increased risk of Systemic Lupus Erythematosus (SLE),” Annals of Human Genetics, vol. 71, part 3, pp. 308–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Graham, C. Kyogoku, S. Sigurdsson et al., “Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 16, pp. 6758–6763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Harley, M. E. Alarcón-Riquelme, L. A. Criswell et al., “Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci,” Nature Genetics, vol. 40, no. 2, pp. 204–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Kaufman, J. A. Kelly, B. J. Herring et al., “Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 54, no. 8, pp. 2533–2540, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kawasaki, C. Kyogoku, J. Ohashi et al., “Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 826–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Kelly, J. M. Kelley, K. M. Kaufman et al., “Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans,” Genes & Immunity, vol. 9, no. 3, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. V. Kozyrev and M. E. Alarcon-Riquelme, “The genetics and biology of Irf5-mediated signaling in lupus,” Autoimmunity, vol. 40, no. 8, pp. 591–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. L. Moser, B. R. Neas, J. E. Salmon et al., “Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14869–14874, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. K. L. Moser, J. A. Kelly, C. J. Lessard, and J. B. Harley, “Recent insights into the genetic basis of systemic lupus erythematosus,” Genes & Immunity, vol. 10, no. 5, pp. 373–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. T. W. Harley, K. M. Kaufman, C. D. Langefeld, J. B. Harley, and J. A. Kelly, “Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies,” Nature Reviews Genetics, vol. 10, no. 5, pp. 285–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. B. Niewold, J. A. Kelly, M. H. Flesch, L. R. Espinoza, J. B. Harley, and M. K. Crow, “Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients,” Arthritis & Rheumatism, vol. 58, no. 8, pp. 2481–2487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. V. Reddy, R. Velázquez-Cruz, V. Baca et al., “Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans,” Human Genetics, vol. 121, no. 6, pp. 721–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. R. Graham, S. V. Kozyrev, E. C. Baechler et al., “A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus,” Nature Genetics, vol. 38, no. 5, pp. 550–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sigurdsson, G. Nordmark, S. Garnier et al., “A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5,” Human Molecular Genetics, vol. 17, no. 18, pp. 2868–2876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Martin, J. M. Jae, D. Walls, and S. D. Hayward, “Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus,” Journal of Virology, vol. 81, no. 18, pp. 9748–9758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. J. Barnes, J. Richards, M. Mancl, S. Hanash, L. Beretta, and P. M. Pitha, “Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection,” The Journal of Biological Chemistry, vol. 279, no. 43, pp. 45194–45207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Yasuda, C. Richez, J. W. Maciaszek et al., “Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes Is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production,” The Journal of Immunology, vol. 178, no. 11, pp. 6876–6885, 2007. View at Scopus
  26. T. B. Niewold, J. Hua, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes & Immunity, vol. 8, no. 6, pp. 492–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. J. Harley, I. T. W. Harley, J. M. Guthridge, and J. A. James, “The curiously suspicious: a role for Epstein-Barr virus in lupus,” Lupus, vol. 15, no. 11, pp. 768–777, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. B. Harley and J. A. James, “Epstein-Barr virus infection induces lupus autoimmunity,” Bulletin of the NYU Hospital for Joint Diseases, vol. 64, no. 1-2, pp. 45–50, 2006. View at Scopus
  29. J. A. James and J. B. Harley, “Epstein-Barr virus infection may be an environmental risk factor for SLE in children and teenagers,” Arthritis & Rheumatism, vol. 42, pp. 1122–1126, 1999.
  30. J. A. James, J. B. Harley, and R. H. Scofield, “Epstein-Barr virus and systemic lupus erythematosus,” Current Opinion in Rheumatology, vol. 18, no. 5, pp. 462–467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. James, K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. A. Lehman, and J. B. Harley, “An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus,” The Journal of Clinical Investigation, vol. 100, no. 12, pp. 3019–3026, 1997. View at Scopus
  32. J. A. James, B. R. Neas, K. L. Moser et al., “Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure,” Arthritis & Rheumatism, vol. 44, no. 5, pp. 1122–1126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J. J. Y. Lu, D. Y. Chen, C. W. Hsieh, J. L. Lan, F. J. Lin, and S. H. Lin, “Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan,” Lupus, vol. 16, no. 3, pp. 168–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. James, R. H. Scofield, and J. B. Harley, “Lupus humoral autoimmunity after short peptide immunization,” Annals of the New York Academy of Sciences, vol. 815, pp. 124–127, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. B. D. Poole, R. H. Scofield, J. B. Harley, and J. A. James, “Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus,” Autoimmunity, vol. 39, no. 1, pp. 63–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Sabbatini, S. Bombardieri, and P. Migliorini, “Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I,” European Journal of Immunology, vol. 23, no. 5, pp. 1146–1152, 1993. View at Scopus
  37. A. Sabbatini, M. P. Dolcher, B. Marchini, S. Bombardieri, and P. Migliorini, “Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus,” The Journal of Rheumatology, vol. 20, no. 10, pp. 1679–1683, 1993. View at Scopus
  38. K. Sundar, S. Jacques, P. Gottlieb et al., “Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies,” Journal of Autoimmunity, vol. 23, no. 2, pp. 127–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. B. D. Poole, T. Gross, S. Maier, J. B. Harley, and J. A. James, “Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments,” Journal of Autoimmunity, vol. 31, no. 4, pp. 362–371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. T. McClain, B. D. Poole, B. F. Bruner, K. M. Kaufman, J. B. Harley, and J. A. James, “An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 54, no. 1, pp. 360–368, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Kang, T. Quan, H. Nolasco et al., “Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus,” The Journal of Immunology, vol. 172, no. 2, pp. 1287–1294, 2004. View at Scopus
  42. U. Y. Moon, S. J. Park, S. T. Oh et al., “Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood,” Arthritis Research & Therapy, vol. 6, no. 4, pp. R295–302, 2004. View at Scopus
  43. G. J. Babcock, D. Hochberg, and A. D. Thorley-Lawson, “The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell,” Immunity, vol. 13, no. 4, pp. 497–506, 2000. View at Scopus
  44. N. Knowlton, I. M. Dozmorov, and M. Centola, “Microarray data analysis toolbox (MDAT): for normalization, adjustment and analysis of gene expression data,” Bioinformatics, vol. 20, no. 18, pp. 3687–3690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. V. K. Mootha, C. M. Lindgren, K. F. Eriksson et al., “PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,” Nature Genetics, vol. 34, no. 3, pp. 267–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. V. Kozyrev, S. Lewén, P. M. V. L. Reddy et al., “Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 56, no. 4, pp. 1234–1241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Subramanian, K. Tus, Q. Z. Li et al., “A Tlr7 translocation accelerates systemic autoimmunity in murine lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 26, pp. 9970–9975, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Dumont, R. Henderson, and V. L. Tybulewicz, “Characterization of the roles of Rac1 and Rac2 GTPases in lymphocyte development,” Methods in Enzymology, vol. 439, pp. 235–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Bennett, A. K. Palucka, E. Arce et al., “Interferon and granulopoiesis signatures in systemic lupus erythematosus blood,” The Journal of Experimental Medicine, vol. 197, no. 6, pp. 711–723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. C. Baechler, F. M. Batliwalla, G. Karypis et al., “Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2610–2615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. K. Crow, “Interferon-α: a new target for therapy in systemic lupus erythematosus?” Arthritis & Rheumatism, vol. 48, no. 9, pp. 2396–2401, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. T. B. Niewold, D. N. Clark, R. Salloum, and B. D. Poole, “Interferon alpha in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 948364, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Batteux, P. Palmer, M. Daëron, B. Weill, and P. Lebon, “FCγRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus,” European Cytokine Network, vol. 10, no. 4, pp. 509–514, 1999. View at Scopus
  55. U. Bave, M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, and L. Rönnblom, “FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG,” The Journal of Immunology, vol. 171, no. 6, pp. 3296–3302, 2003.
  56. T. Lovgren, M.-L. Eloranta, U. Bave, G. V. Alm, and L. Rönnblom, “Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG,” Arthritis & Rheumatism, vol. 50, no. 6, pp. 1861–1872, 2004. View at Publisher · View at Google Scholar
  57. T. Lovgren, M.-L. Eloranta, B. Kastner, M. Wahren-Herlenius, G. V. Alm, and L. Rönnblom, “Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome auto antigen—associated RNA,” Arthritis & Rheumatism, vol. 54, no. 6, pp. 1917–1927, 2006. View at Publisher · View at Google Scholar
  58. L. Rönnblom and G. V. Alm, “Systemic lupus erythematosus and the type I interferon system,” Arthritis Research & Therapy, vol. 5, no. 2, pp. 68–75, 2003. View at Scopus
  59. L. Rönnblom and V. Pascual, “The innate immune system in SLE: type I interferons and dendritic cells,” Lupus, vol. 17, no. 5, pp. 394–399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Tian, A. M. Avalos, S. Y. Mao et al., “Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE,” Nature Immunology, vol. 8, no. 5, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. B. J. Barnes, A. E. Field, and P. M. Pitha-Rowe, “Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes,” The Journal of Biological Chemistry, vol. 278, no. 19, pp. 16630–16641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. B. J. Barnes, P. A. Moore, and P. M. Pitha, “Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes,” The Journal of Biological Chemistry, vol. 276, no. 26, pp. 23382–23390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. A. Savitsky, H. Yanai, T. Tamura, T. Taniguchi, and K. Honda, “Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 22, pp. 10154–10159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. L. Werner, J. D. Kearns, V. Zadorozhnaya et al., “Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20,” Genes & Development, vol. 22, no. 15, pp. 2093–2101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. R. R. Graham, C. Cotsapas, L. Davies et al., “Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1059–1061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. N. I. Kang, H. Y. Yoon, Y. R. Lee et al., “A20 attenuates allergic airway inflammation in mice,” The Journal of Immunology, vol. 183, no. 2, pp. 1488–1495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Trynka, A. Zhernakova, J. Romanos et al., “Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling,” Gut, vol. 58, no. 8, pp. 1078–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. S. Bates, C. J. Lessard, J. M. Leon et al., “Meta-analysis and imputation identifies a 109kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations,” Genes & Immunity, vol. 10, no. 5, pp. 470–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Gateva, J. K. Sandling, G. Hom et al., “A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1228–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. J. W. Han, H. F. Zheng, Y. Cui et al., “Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1234–1237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. S. L. Musone, K. E. Taylor, T. T. Lu et al., “Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1062–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Honma, S. Tsuzuki, M. Nakagawa et al., “TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas,” Blood, vol. 114, no. 12, pp. 2467–2475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Kato, M. Sanada, I. Kato et al., “Frequent inactivation of A20 in B-cell lymphomas,” Nature, vol. 459, no. 7247, pp. 712–716, 2009. View at Publisher · View at Google Scholar · View at Scopus